111, Inc. Announces Establishment of the Special Committee
Why now
Thesis: Special committee hints at strategic review at YI
Catalyst to watch: Committee findings or transaction announcement
Main risk: Committee may conclude with no deal
Why it matters
A special committee formation at 111, Inc. often precedes strategic review or a transaction, but no terms are disclosed.
Details
SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the...
Related assets & topics
HealthcareChinaSources
- prnewswire · 2026-09-28 08:30 UTC